About Telix Pharmaceuticals (AMER)
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- North Melbourne, Victoria
- Company type
- Public Company
- Company profile name
- Telix Pharmaceuticals Limited
Telix is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic ('theranostic') radiopharmaceuticals. Telix is headquartered in Melbourne, Australia with commercial operations in the United States, Europe (Belgium and Switzerland) and Japan. Telix is developing a portfolio of radiopharmaceutical products that aims to address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX).
Specialties
- Oncology
- Theranostics
- Radiology
- Radiopharmaceuticals
- Cancer
- Prostate Cancer
- Renal Cancer
- Glioblastoma
- Positron Emission Tomography
- Nuclear Medicine
- Molecularly Targeted Radiation
- Urology
- Molecular Imaging
- Cancer Imaging
- and Cancer Therapy
Company locations
55 Flemington Rd, North Melbourne, Victoria 3051, AU
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 65,350
- People linked to this company
- 1,134
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.